iopromide has been researched along with Kidney Failure, Chronic in 17 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
Excerpt | Relevance | Reference |
---|---|---|
"Contrast induced acute kidney injury is one of the most frequent causes of hospital acquired acute kidney injury." | 2.77 | Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial. ( Binder, C; Jaberi, A; Kitzler, TM; Kotanko, P; Petnehazy, E; Rehak, P; Sendlhofer, G; Stacher, R, 2012) |
"Twenty stable patients with chronic renal failure after coronary angiography were investigated for contrast medium elimination during hemodialysis directly after contrast medium application." | 1.31 | Reduced iopromide elimination in hemodialysis with cuprophan membranes. ( Hohage, H; Kisters, K; Koeneke, J; Matzkies, FK; Reinecke, H; Schaefer, RM; Tombach, B, 2000) |
"Iopromide proved itself to be an x-ray contrast medium with a low rate of side effects, which can be effectively eliminated from the body by means of conventional dialysis." | 1.28 | Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis. ( Hollmann, HJ; Kierdorf, H; Kindler, J; Speck, U; Vorwerk, D; Winterscheid, R, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 7 (41.18) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kang, TW | 1 |
Kim, CK | 1 |
Wi, J | 1 |
Ko, YG | 1 |
Kim, JS | 1 |
Kim, BK | 1 |
Choi, D | 1 |
Ha, JW | 1 |
Hong, MK | 1 |
Jang, Y | 1 |
Dhawan, A | 1 |
Parikh, D | 1 |
Shugman, I | 1 |
French, J | 1 |
Hallani, H | 1 |
Fernandes, C | 1 |
Juergens, CP | 1 |
Schönefeld, E | 1 |
Höwler, S | 1 |
Osada, N | 1 |
Torsello, G | 1 |
Kim, IY | 1 |
Lee, SB | 1 |
Lee, DW | 1 |
Song, SH | 1 |
Seong, EY | 1 |
Kwak, IS | 1 |
Kitzler, TM | 1 |
Jaberi, A | 1 |
Sendlhofer, G | 1 |
Rehak, P | 1 |
Binder, C | 1 |
Petnehazy, E | 1 |
Stacher, R | 1 |
Kotanko, P | 1 |
Franke, RP | 1 |
Jung, F | 1 |
Hsieh, YC | 1 |
Ting, CT | 1 |
Liu, TJ | 1 |
Wang, CL | 1 |
Chen, YT | 1 |
Lee, WL | 1 |
Dittrich, E | 1 |
Puttinger, H | 1 |
Schillinger, M | 1 |
Lang, I | 1 |
Stefenelli, T | 1 |
Hörl, WH | 1 |
Vychytil, A | 1 |
Dussol, B | 1 |
Morange, S | 1 |
Loundoun, A | 1 |
Auquier, P | 1 |
Berland, Y | 1 |
Bell, KW | 1 |
Heng, RC | 1 |
Atallah, J | 1 |
Chaitowitz, I | 1 |
Möckel, M | 1 |
Radovic, M | 1 |
Kühnle, Y | 1 |
Combé, V | 1 |
Waigand, J | 1 |
Schröder, S | 1 |
Dietz, R | 1 |
Frei, U | 1 |
Eckardt, KU | 1 |
Gare, M | 1 |
Haviv, YS | 1 |
Ben-Yehuda, A | 1 |
Rubinger, D | 1 |
Bdolah-Abram, T | 1 |
Fuchs, S | 1 |
Gat, O | 1 |
Popovtzer, MM | 1 |
Gotsman, MS | 1 |
Mosseri, M | 1 |
Matzkies, FK | 1 |
Reinecke, H | 1 |
Tombach, B | 1 |
Koeneke, J | 1 |
Hohage, H | 1 |
Kisters, K | 1 |
Schaefer, RM | 1 |
Knof, J | 1 |
Pommer, W | 1 |
Kern, D | 1 |
Kierdorf, H | 1 |
Kindler, J | 1 |
Winterscheid, R | 1 |
Hollmann, HJ | 1 |
Vorwerk, D | 1 |
Speck, U | 1 |
Meyrier, A | 1 |
Fernet, M | 1 |
Rainfray, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention[NCT03266458] | 210 participants (Anticipated) | Observational [Patient Registry] | 2018-01-01 | Not yet recruiting | |||
Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 trials available for iopromide and Kidney Failure, Chronic
Article | Year |
---|---|
[Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon; Contrast Media; Cost-Benefit Analysis; C | 2011 |
Efficacy of vitamin E and N-acetylcysteine in the prevention of contrast induced kidney injury in patients with chronic kidney disease: a double blind, randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Double-Blind Method; Female; Free Radical | 2012 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography.
Topics: Cardiotonic Agents; Contrast Media; Coronary Angiography; Creatinine; Diabetes Complications; Dopami | 1999 |
13 other studies available for iopromide and Kidney Failure, Chronic
Article | Year |
---|---|
Pleuroperitoneal communication of peritoneal dialysis demonstrated by multidetector-row CT peritoneography.
Topics: Contrast Media; Female; Humans; Hydrothorax; Iohexol; Kidney Failure, Chronic; Middle Aged; Peritone | 2009 |
Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Acute Kidney Injury; Adult; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Disease Progressio | 2011 |
Contrast induced nephropathy in patients with pre-existing renal impairment undergoing invasive coronary procedures - a long-term follow-up.
Topics: Cohort Studies; Contrast Media; Coronary Angiography; Creatinine; Follow-Up Studies; Glomerular Filt | 2011 |
Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients.
Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Kidney; Kidney Failure, C | 2012 |
Pathophysiology of the contrast media-induced nephropathy (CIN) in patients undergoing coronary interventions.
Topics: Animals; Contrast Media; Coronary Angiography; Humans; Iohexol; Kidney; Kidney Diseases; Kidney Fail | 2013 |
Short- and long-term renal outcomes of immediate prophylactic hemodialysis after cardiovascular catheterizations in patients with severe renal insufficiency.
Topics: Acute Kidney Injury; Aged; Angina, Unstable; Cardiac Catheterization; Contrast Media; Coronary Angio | 2005 |
Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
Topics: Aged; Analysis of Variance; Case-Control Studies; Contrast Media; Creatinine; Female; Follow-Up Stud | 2006 |
Use of intra-arterial multi-detector row CT angiography for the evaluation of an ischaemic limb in a patient with renal impairment.
Topics: Aged; Angiography, Digital Subtraction; Contraindications; Contrast Media; Female; Humans; Image Int | 2006 |
Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography.
Topics: Acute Kidney Injury; Aged; Blood Flow Velocity; Contrast Media; Coronary Angiography; Creatinine; Fe | 2008 |
Reduced iopromide elimination in hemodialysis with cuprophan membranes.
Topics: Cellulose; Contrast Media; Humans; Iohexol; Kidney Failure, Chronic; Membranes, Artificial; Polymers | 2000 |
[Permeability disorders of the blood-brain barrier following intravascular contrast medium administration in kidney failure].
Topics: Aged; Blood-Brain Barrier; Brain; Brain Edema; Cell Membrane Permeability; Contrast Media; Coronary | 1992 |
Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.
Topics: Adult; Aged; Anuria; Contrast Media; Female; Humans; Iohexol; Kidney Failure, Chronic; Male; Metabol | 1989 |
[Renal tolerability of iopromide 370 in patients with chronic renal insufficiency].
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Glomerular Filtration Rate; Humans; Iohexol; Kidney; | 1989 |